How I made unicorn company in Bioeconomy Industry
Please note that tea will be provided after the seminar. Event registration here.
The Chitose group is headquartered in Singapore and operates in Japan, Malaysia, Brunei, and the Netherlands. In this seminar, Tomohiro Fujita, founder and CEO of Chitose Group, will give insights on how he and his team have managed to transform Chitose into a unicorn company, as well as how they intend to contribute to the development of a new economic zone in Southeast Asia from their Singapore base.
Tomohiro Fujita, PhD, graduated from the University of Tokyo, Graduate School of Agriculture and Life Sciences. Throughout his time in university, Fujita was thinking how to create a society based on biotechnology that is necessary to humans. He swore to seek a way to implement biotechnology in society not as a scholar but as a businessman. While learning actual business management at the Strategy Consulting Department in Accenture Japan, he studied the concepts and perspectives of business management that is required in the future bio industry.
He established numerous social problem-solving biotechnology companies, starting with Chitose Laboratory Corp, and grew them. He is looking for a better way to turn cutting-edge biotechnology into businesses and provide them to society.
Chitose Group is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. Chitose Group is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technological development capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology.